Thank you for being here today.
Ms. Fuller, I would like to come back to your earlier comments. You said that Health Canada is speeding up some of its processes and that the target should be the safety and efficacy of drugs. You were talking about expediting approvals within 300 days. I would like to raise the issue of a drug that has been put on the market, Gardasil. Were the clinical trials really focussed on ensuring the safety of that drug?
When we hear about deaths in Europe and the United States, isn't it risky for the Public Health Agency of Canada to pursue a mass vaccination program for girls from the age of 15? How might Health Canada react towards a product that has been marketed elsewhere but which has caused harm and even deaths?